+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Human Microbiome Therapeutics Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change

  • ID: 5232520
  • Report
  • December 2020
  • Region: Global
  • 181 pages
  • The Business Research Company

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Assembly Biosciences
  • Enterome Bioscience
  • Second Genome Inc.
  • Seres Therapeutics
  • Vedanta BioSciences
Human Microbiome Therapeutics Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global human microbiome therapeutics market.

Reasons to Purchase
  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
Description:

Where is the largest and fastest growing market for the human microbiome therapeutics market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global human microbiome therapeutics market opportunities and strategies to 2030 report answers all these questions and many more.

The report covers the following chapters
  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography and segmentation by disease, and by sequencing technology type.
  • Market Characteristics - The market characteristics section of the report defines and explains the human microbiome therapeutics market. This chapter also defines and describes products covered in the report.
  • Trends and Strategies - This chapter describes the major trends shaping the global human microbiome therapeutics market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
COVID Impact Analysis - This section provides an insight on how the pandemic is impacting the human microbiome therapeutics market.
  • Global Market Size and Growth - This section contains the global forecast (2023-2025), (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the forecast periods.
  • Regional Analysis - This section contains the forecast (2023-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation - This section contains the market values (2023-2030) and analysis for different segments.
  • Regional Market Size and Growth - This section contains the region’s market size forecast (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape - This section covers details on the competitive landscape of the global human microbiome therapeutics market, estimated market shares and company profiles for the leading players.
  • Key Mergers and Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities and Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions and Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for human microbiome therapeutics companies in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered: The global human microbiome therapeutics market is segmented by -
  • By Disease: Infectious Diseases; Gastrointestinal Disorders; Metabolic Disorders; Cancers; Other Diseases
  • By Sequencing Technology Type: Targeted Gene; RNA; Whole-Genome Shotgun (WGS); Others Types
Companies Mentioned: Seres Therapeutics; Assembly Biosciences; Enterome Bioscience; Vedanta BioSciences; Second Genome Inc.

Countries: China, India, Japan, Australia, Indonesia, South Korea, USA, Brazil, France, Germany, UK, Russia

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Assembly Biosciences
  • Enterome Bioscience
  • Second Genome Inc.
  • Seres Therapeutics
  • Vedanta BioSciences
1. Human Microbiome Therapeutics Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1. Segmentation by Geography

7. Human Microbiome Therapeutics Market Characteristics
7.1. Market Definition
7.2. Segmentation by Disease
7.2.1. Infectious Diseases
7.2.2. Gastrointestinal Disorders
7.2.3. Metabolic Disorders
7.2.4. Cancers
7.2.5. Other Diseases
7.3. Segmentation by Sequencing Technology Type
7.3.1. Targeted Gene
7.3.2. RNA
7.3.3. Whole-Genome Sequencing (WGS)- Shotgun
7.3.4. Others Types

8. Human Microbiome Therapeutics Market Trends and Strategies
8.1. Strategic Collaborations and Agreements
8.2. Increasing Number of Pipeline Studies and Drug Development
8.3. Increasing Investments On Development of Cancer Microbiome Therapeutics

9. COVID Impact Human Microbiome Therapeutics Market

10. Global Human Microbiome Therapeutics Market Size and Growth
10.1. Forecast Market Growth, 2023-2030, Value ($ Million)
10.1.1. Drivers of The Market 2023-2030
10.1.2. Restraints On The Market 2023-2030

11. Human Microbiome Therapeutics Market, Regional Analysis
11.1. Global Human Microbiome Therapeutics Market, by Region, Forecast, 2023-2030, Value ($ Million)
11.2. Global Human Microbiome Therapeutics Market, by Country, Forecast, 2023-2030, Value ($ Million)

12. Global Human Microbiome Therapeutics Market Segmentation
12.1. Global Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)
12.1.1. Infectious Diseases
12.1.2. Cancers
12.1.3. Gastrointestinal Disorders
12.1.4. Metabolic Disorders
12.2. Global Human Microbiome Therapeutics Market, Segmentation by Sequencing Technology Type, Forecast, 2023-2030, Value ($ Million)
12.2.1. Targeted Gene
12.2.2. RNA
12.2.3. Whole-genome Shotgun
12.2.4. Other Type

13. Asia-Pacific Human Microbiome Therapeutics Market
13.1. Asia-Pacific Human Microbiome Therapeutics Market Overview
13.1.1. Region Information
13.1.2. Impact of COVID-19
13.1.3. Market Information
13.1.4. Background Information
13.1.5. Government Initiatives
13.1.6. Regulations
13.1.7. Regulatory Bodies
13.1.8. Major Associations
13.1.9. Taxes Levied
13.1.10. Corporate Tax Structure
13.1.11. Investment
13.1.12. Major Companies
13.2. Asia-Pacific Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
13.3. Asia-Pacific Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)
13.4. Asia-Pacific Human Microbiome Therapeutics Market: Country Analysis
13.5. China Human Microbiome Therapeutics Market
13.6. China Human Microbiome Therapeutics Market Overview
13.6.1. Country Information
13.6.2. Impact of COVID-19
13.6.3. Market Information
13.6.4. Background Information
13.6.5. Regulations
13.6.6. Regulatory Bodies
13.6.7. Major Associations
13.6.8. Corporate Tax Structure
13.6.9. Investment
13.6.10. Major Companies
13.7. China Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
13.8. China Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)
13.9. India Human Microbiome Therapeutics Market
13.10. India Human Microbiome Therapeutics Market Overview
13.10.1. Country Information
13.10.2. Impact of COVID-19
13.10.3. Market Information
13.10.4. Background Information
13.10.5. Government Initiatives
13.10.6. Regulations
13.10.7. Regulatory Bodies
13.10.8. Major Associations
13.10.9. Corporate Tax Structure
13.10.10. Major Companies
13.11. India Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
13.12. India Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)
13.13. Japan Human Microbiome Therapeutics Market
13.14. Japan Human Microbiome Therapeutics Market Overview
13.14.1. Country Information
13.14.2. Impact of COVID-19
13.14.3. Market Information
13.14.4. Background Information
13.14.5. Regulations
13.14.6. Regulatory Bodies
13.14.7. Corporate Tax Structure
13.14.8. Investment
13.14.9. Major Companies
13.15. Japan Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
13.16. Japan Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)
13.17. Australia Human Microbiome Therapeutics Market
13.18. Australia Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
13.19. Australia Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)
13.20. Indonesia Human Microbiome Therapeutics Market
13.21. Indonesia Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
13.22. Indonesia Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)
13.23. South Korea Human Microbiome Therapeutics Market
13.24. South Korea Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
13.25. South Korea Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)

14. Western Europe Human Microbiome Therapeutics Market
14.1. Western Europe Human Microbiome Therapeutics Market Overview
14.1.1. Region Information
14.1.2. Impact of COVID-19
14.1.3. Market Information
14.1.4. Background Information
14.1.5. Government initiatives
14.1.6. Regulations
14.1.7. Regulatory Bodies
14.1.8. Major Associations
14.1.9. Taxes Levied
14.1.10. Corporate Tax Structure
14.1.11. Investment
14.1.12. Major Companies
14.2. Western Europe Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
14.3. Western Europe Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)
14.4. Western Europe Human Microbiome Therapeutics Market: Country Analysis
14.5. UK Human Microbiome Therapeutics Market
14.6. UK Human Microbiome Therapeutics Market Overview
14.6.1. Country Information
14.6.2. Impact of COVID-19
14.6.3. Market Information
14.6.4. Background Information
14.6.5. Government Initiatives
14.6.6. Regulations
14.6.7. Regulatory Bodies
14.6.8. Major Associations
14.6.9. Taxes Levied
14.6.10. Corporate Tax Structure
14.6.11. Investment
14.6.12. Major Companies
14.7. UK Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
14.8. UK Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)
14.9. Germany Human Microbiome Therapeutics Market
14.10. Germany Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
14.11. Germany Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)
14.12. France Human Microbiome Therapeutics Market
14.13. France Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
14.14. France Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)

15. Eastern Europe Human Microbiome Therapeutics Market
15.1. Eastern Europe Human Microbiome Therapeutics Market Overview
15.1.1. Region Information
15.1.2. Impact of COVID-19
15.1.3. Market Information
15.1.4. Background Information
15.1.5. Government Initiatives
15.1.6. Regulations
15.1.7. Regulatory Bodies
15.1.8. Major Associations
15.1.9. Taxes Levied
15.1.10. Corporate Tax Structure
15.1.11. Investments
15.1.12. Major Companies
15.2. Eastern Europe Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
15.3. Eastern Europe Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)
15.4. Eastern Europe Human Microbiome Therapeutics Market: Country Analysis
15.5. Russia Human Microbiome Therapeutics Market
15.6. Russia Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
15.7. Russia Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)

16. North America Human Microbiome Therapeutics Market
16.1. North America Human Microbiome Therapeutics Market Overview
16.1.1. Region Information
16.1.2. Impact of COVID-19
16.1.3. Market Information
16.1.4. Background Information
16.1.5. Government Initiatives
16.1.6. Regulations
16.1.7. Regulatory Bodies
16.1.8. Major Associations
16.1.9. Taxes Levied
16.1.10. Corporate Tax Structure
16.1.11. Investment
16.1.12. Major Companies
16.2. North America Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
16.3. North America Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)
16.4. North America Human Microbiome Therapeutics Market: Country Analysis
16.5. USA Human Microbiome Therapeutics Market
16.6. USA Human Microbiome Therapeutics Market Overview
16.6.1. Country Information
16.6.2. Impact of COVID-19
16.6.3. Market Information
16.6.4. Background Information
16.6.5. Government Initiatives
16.6.6. Regulations
16.6.7. Regulatory Bodies
16.6.8. Major Associations
16.6.9. Corporate Tax Structure
16.6.10. Investments
16.6.11. Major Companies
16.7. USA Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
16.8. USA Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)

17. South America Human Microbiome Therapeutics Market
17.1. South America Human Microbiome Therapeutics Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. Impact of COVID-19
17.1.4. Background Information
17.1.5. Government Initiatives
17.1.6. Regulations
17.1.7. Regulatory Bodies
17.1.8. Major Associations
17.1.9. Taxes Levied
17.1.10. Corporate Tax Structure
17.1.11. Investments
17.1.12. Major Companies
17.2. South America Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
17.3. South America Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)
17.4. South America Human Microbiome Therapeutics Market: Country Analysis
17.5. Brazil Human Microbiome Therapeutics Market
17.6. Brazil Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
17.7. Brazil Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)

18. Middle East Human Microbiome Therapeutics Market
18.1. Middle East Human Microbiome Therapeutics Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. Impact of COVID-19
18.1.4. Background Information
18.1.5. Government Initiatives
18.1.6. Regulations
18.1.7. Regulatory Bodies
18.1.8. Major Associations
18.1.9. Taxes Levied
18.1.10. Corporate Tax Structure
18.1.11. Investments
18.1.12. Major Companies
18.2. Middle East Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
18.3. Middle East Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)

19. Africa Human Microbiome Therapeutics Market
19.1. Africa Human Microbiome Therapeutics Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. Impact of COVID-19
19.1.4. Background Information
19.1.5. Government Initiatives
19.1.6. Regulations
19.1.7. Regulatory Bodies
19.1.8. Major Associations
19.1.9. Taxes Levied
19.1.10. Corporate Tax Structure
19.1.11. Investments
19.1.12. Major Companies
19.2. Africa Human Microbiome Therapeutics Market, Forecast Market Growth, 2023-2030, Value ($ Million)
19.3. Africa Human Microbiome Therapeutics Market, Segmentation by Disease, Forecast, 2023-2030, Value ($ Million)

20. Global Human Microbiome Therapeutics Market Competitive Landscape
20.1. Company Profiles
20.2. Seres Therapeutics
20.2.1. Company Overview
20.2.2. Products and Services
20.2.3. Business Strategy
20.2.4. Financial Overview
20.3. Assembly Biosciences
20.3.1. Company Overview
20.3.2. Products and Services
20.3.3. Business Strategy
20.3.4. Financial Overview
20.4. Enterome Bioscience
20.4.1. Company Overview
20.4.2. Products and Services
20.4.3. Business Strategy
20.4.4. Financial Overview
20.5. Vedanta BioSciences
20.5.1. Company Overview
20.5.2. Products and Services
20.5.3. Business Strategy
20.5.4. Financial Overview
20.6. Second Genome Inc.
20.6.1. Company Overview
20.6.2. Products and Services
20.6.3. Business Strategy
20.6.4. Financial Overview

21. Key Mergers and Acquisitions in The Human Microbiome Therapeutics Market
21.1. Janssen Collaborated With Kaleido Biosciences
21.2. Ritter Pharmaceuticals Merged With Qualigen, Inc.
21.3. Ferring Pharmaceuticals Acquired Rebiotix
21.4. Monsanto Collaborated With Second Genome

22. Human Microbiome Therapeutics Market Opportunities and Strategies
22.1. Global Human Microbiome Therapeutics Market in 2030 - Countries Offering Most New Opportunities
22.2. Global Human Microbiome Therapeutics Market in 2030 - Segments Offering Most New Opportunities
22.3. Global Human Microbiome Therapeutics Market in 2023 - Growth Strategies
22.3.1. Market Trend Based Strategies
22.3.2. Competitor Strategies

23. Microbiome Homes Market, Conclusions and Recommendations
23.1. Conclusions
23.2. Recommendations
23.2.1. Product
23.2.2. Place
23.2.3. Price
23.2.4. Promotion
23.2.5. People

24. Appendix
24.1. Market Data Sources
24.2. Research Methodology
24.3. Currencies
24.4. Research Inquiries
24.5. About the Publisher
24.6. Copyright and Disclaimer
24.7.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Assembly Biosciences
  • Enterome Bioscience
  • Second Genome Inc.
  • Seres Therapeutics
  • Vedanta BioSciences
This report describes and evaluates the global human microbiome therapeutics market in the forecast period. It covers the forecast period, 2023-2025 forecast period, and 2025-2030 the forecast period.

The global human microbiome therapeutics market is expected to reach a value of nearly $148.6 million in 2025, having increased at a compound annual growth rate (CAGR) of 21.9% since 2023. The market is expected to increase from $148.6 million in 2025 to $400.0 million in 2030 having increasing at growth rate of 21.9%.

Growth is forecast period is expected to drive by increase in funding, increase in prevalence of chronic diseases and technological advances. Factors that could hinder the growth of the human microbiome therapeutics market in the future include ethical issues associated with the market.

The human microbiome therapeutics market is segmented disease into infectious diseases, gastrointestinal disorders, metabolic disorders, cancers and other diseases. The infectious diseases market was the largest segment of the human microbiome therapeutics market segmented by disease, accounting for 70.9% of the total in 2030. It is also expected to be the fastest growing segment in the human microbiome therapeutics market segmented by disease, at a CAGR of 15.7% during 2025-2030.

The human microbiome therapeutics market is also segmented by sequencing technology type into targeted gene, RNA, whole-genome sequencing (WGS) and others. The global RNA market was the largest segment of the human microbiome therapeutics market segmented by sequencing technology type, accounting for 32.5% of the total in 2023. Going forward, the whole genome shotgun segment is expected to be the fastest growing segment in the human microbiome therapeutics market segmented by sequencing technology type, going forward, at a CAGR of 18.2% during 2025-2030.

North America was the largest region in the global human microbiome therapeutics market, accounting for 52.8% of the total in 2030. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the human microbiome therapeutics market will be Asia Pacific and North America where growth will be at CAGRs of 47.4% and 21.6% respectively. These will be followed by Eastern Europe, and South America, where the markets are expected to grow at CAGRs of 19.3% and 15.6% respectively.

The global human microbiome therapeutics market is an emerging market. Top 10 players in the market include Seres Therapeutics, Assembly Biosciences, Enterome Bioscience, Vedanta BioSciences, Second Genome Inc., ViThera Pharmaceuticals Inc., Osel, Rebiotix, Inc., MicroBiome Therapeutics LLC and MaaT Pharma.

The top opportunities in the human microbiome therapeutics market segmented by disease will arise in the infectious disease segment, which will gain $183.5 million of global annual sales by 2030. The top opportunities in the human microbiome therapeutics market segmented by sequencing technology type will arise in the whole-genome shotgun market segment, which will gain $115.2 million of global annual sales by 2030.

Market-trend-based strategies for the human microbiome therapeutics market include investing in the strategic collaboration and research and development of microbiome therapeutics for treating cancers. Player-adopted strategies in the human microbiome therapeutics market include expanding through strategic collaborations.

The COVID-19 pandemic has decreased short-term potential growth opportunities for the microbiome industry.

To take advantage of the opportunities, the publisher recommends the microbiomes market companies to focus on strategic collaborations and agreements, focus on pipeline studies and drug development, focus on increasing investments for development of cancer microbiome therapeutics, establish operations in emerging markets, leverage online pharmacies, set up authorized distributors and sales representatives, provide competitively priced offerings in low-income countries to reach new users, offer skimmed pricing for innovative drugs, participate in trade shows and events, increase adoption of the internet and social media, target local pharmacies to spread awareness, focus on digestive health and focus on the increased requirement of R&D scientists
Note: Product cover images may vary from those shown
  • Seres Therapeutics
  • Assembly Biosciences
  • Enterome Bioscience
  • Vedanta BioSciences
  • Second Genome Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll